Shattuck Labs (STTK) Change in Account Payables (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Change in Account Payables of -$911000.0 for Q1 2026, down 2.82% year-over-year from -$937451.8 in Q1 2025, and down 197.02% quarter-over-quarter from $939000.0 in Q4 2025.
Powered by 
Analysis
Shattuck Labs (STTK) Change in Account Payables (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Change in Account Payables for 8 consecutive years, with -$911000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables fell 2.82% year-over-year to -$911000.0; the TTM figure through Mar 2026 stood at -$343000.0 (up 64.27% YoY), while the FY2025 annual figure was -$318000.0, down 138.22% from the prior year.
- Change in Account Payables fell to -$911000.0 in Q1 2026 per STTK's latest filing, from $939000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $4.4 million in Q4 2022 and bottomed at -$7.7 million in Q1 2022.
- Historically, Change in Account Payables has averaged -$521647.1 across 5 years, with a median of -$475000.0 in 2023.
- Annual changes were most pronounced in 2022 — Change in Account Payables slumped 723.53% — and 2025, when it surged 497.39%.
- Shattuck Labs' Change in Account Payables stood at $4.4 million in 2022, then plunged by 110.91% to -$475000.0 in 2023, then retreated by 6.95% to -$508000.0 in 2024, then surged by 284.84% to $939000.0 in 2025, then plunged by 197.02% to -$911000.0 in 2026.
- Business Quant data shows STTK's Change in Account Payables at -$911000.0 in Q1 2026, $939000.0 in Q4 2025, and $687000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Shattuck Labs | 885.09 Mn | 885.09 Mn | - | 2.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.52 Mn |
| Mar 31, 2026 | -911,000.00 |
| Dec 31, 2025 | 939,000.00 |
| Sep 30, 2025 | 687,000.00 |
| Jun 30, 2025 | -1.06 Mn |
| Mar 31, 2025 | -886,000.00 |
| Dec 31, 2024 | -508,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Jun 30, 2024 | 319,000.00 |
| Mar 31, 2024 | 906,000.00 |
| Dec 31, 2023 | -475,000.00 |
| Sep 30, 2023 | 20,000.00 |
| Jun 30, 2023 | -2.98 Mn |
| Mar 31, 2023 | -2.20 Mn |
| Dec 31, 2022 | 4.36 Mn |
| Sep 30, 2022 | -2.68 Mn |
| Jun 30, 2022 | 3.22 Mn |
| Mar 31, 2022 | -7.74 Mn |
| Dec 31, 2021 | 7.02 Mn |
| Sep 30, 2021 | 1.75 Mn |